E. Kelkitli Et Al. , "Abciximab-induced thrombocytopenia: Correct management," Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.2, pp.581-583, 2022
Kelkitli, E. Et Al. 2022. Abciximab-induced thrombocytopenia: Correct management. Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.2 , 581-583.
Kelkitli, E., Odabaşi Giden, A., Denız Kürekçi, D., & Turgut, M., (2022). Abciximab-induced thrombocytopenia: Correct management. Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.2, 581-583.
Kelkitli, Engin Et Al. "Abciximab-induced thrombocytopenia: Correct management," Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.2, 581-583, 2022
Kelkitli, Engin Et Al. "Abciximab-induced thrombocytopenia: Correct management." Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.2, pp.581-583, 2022
Kelkitli, E. Et Al. (2022) . "Abciximab-induced thrombocytopenia: Correct management." Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.2, pp.581-583.
@article{article, author={Engin Kelkitli Et Al. }, title={Abciximab-induced thrombocytopenia: Correct management}, journal={Journal of Experimental and Clinical Medicine (Turkey)}, year=2022, pages={581-583} }